Close

Press Releases

Global GenAI study reveals optimism and opportunities for healthcare and life sciences

Marlow, UK – Generative AI (GenAI) is at the forefront of global innovation in both healthcare and life sciences. To better understand how technology is being used, data and AI leader SAS and Coleman Parkes Research conducted a global, cross-industry...

Shilpa Biologicals Pvt Ltd signs strategic development partnership with mAbTree Biologics AG for a novel immuno-oncology asset

Basel Switzerland, and Karnataka India:  mAbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd. (a fully owned subsidiary of Shilpa Medicare Limited) for its novel biologic asset for immuno-oncological applications. Under the terms of the strategic...

Sirio Launches Global Research Institute for Longevity Studies [SIA]

Research Institute to advance nutraceutical product development across four core research areas SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – announces the launch of the Sirio Institute for Anti-Ageing (SIA) at the 2025 Boao Health Food Science Conference and...

Shilpa Launches ‘hybrid CDMO’ at DCAT

Shilpa Medicare launches its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a particular therapeutic specialism. In addition to offering...

White Raven, a new Belgian CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing.

White Raven has successfully obtained GMP certification for its state-of-the-art aseptic fill & finish facility. The facility features Cytiva’s SA25 aseptic filling workcell, a fully automated system enhancing sterility assurance and minimizing contamination risks, making it Europe's first...

CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. In Switzerland, CordenPharma will invest >€500m to construct...

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over 2,500 people worldwide and has locations in the Americas, Europe, the Middle East, Africa,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read